Cardio-renal-metabolic (CRM) diseases are not isolated clinical challenges. In Malaysia, conditions such as diabetes, cardiovascular disease, and chronic kidney disease are deeply interconnected, progressive, and increasingly shaping both health outcomes and system demand. Rising diabetes prevalence, increasing dialysis dependence, and growing multi-morbidity are placing sustained clinical and economic pressure on the health system.
Our newly released report, Advancing Cardio-renal-metabolic Health in Malaysia: Connected risks, coordinated solutions, examines this growing burden and makes the case for a coordinated CRM approach as a system imperative. Addressing these conditions in silos risks accelerating disease progression and avoidable costs. Addressing them together creates opportunities for better outcomes, stronger continuity of care, and long-term system sustainability.
The report highlights four critical system shifts needed to strengthen Malaysia’s CRM response:
- Early detection through integrated screening at the primary care level
- Continuity of care across diabetes, cardiovascular, and renal services
- Stronger referral pathways and care coordination frameworks
- Strategic use of digital tools and partnerships to support long-term disease management
Drawing on national data and global best practices, the report outlines actionable recommendations to move from fragmented care towards an integrated, patient-centred CRM model that prioritises prevention, early intervention, and equity.